NCT02454712 - Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 16, 2016

Primary Completion Date

January 18, 2018

Study Completion Date

January 18, 2018

Conditions

Healthy

Interventions

DRUG

PF614

PF614 is an oxycodone prodrug

DRUG

Oxycodone extended-release

Oxycodone extended-release is the comparator drug

DRUG

Naltrexone Hydrochloride

Naltrexone HCl tablets, 50 mg, will be used to block high dose opioid effects in healthy volunteers

Trial Locations (1)

PRA Health Sciences - Early Development Services, Lenexa